Weight-HbA1c-insulin-glucose model for describing disease progression of type 2 diabetes

about

Application of the integrated glucose-insulin model for cross-study characterization of T2DM patients on metformin background treatment.The variability in beta-cell function in placebo-treated subjects with type 2 diabetes: application of the weight-HbA1c-insulin-glucose (WHIG) model.

P2860

Q38838596-35594E7F-1CB4-40FC-8CD0-D40A3454CF4E Q40563141-30B6534F-154C-4554-A3FB-417BAAE5A256

P2860

Weight-HbA1c-insulin-glucose model for describing disease progression of type 2 diabetes

Item

http://www.wikidata.org/entity/Q36506476

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Weight-HbA1c-insulin-glucose model for describing disease progression of type 2 diabetes

@ast

Weight-HbA1c-insulin-glucose model for describing disease progression of type 2 diabetes

@en

type

Item

label

Weight-HbA1c-insulin-glucose model for describing disease progression of type 2 diabetes

@ast

Weight-HbA1c-insulin-glucose model for describing disease progression of type 2 diabetes

@en

prefLabel

Weight-HbA1c-insulin-glucose model for describing disease progression of type 2 diabetes

@ast

Weight-HbA1c-insulin-glucose model for describing disease progression of type 2 diabetes

@en

P1476

Weight-HbA1c-insulin-glucose model for describing disease progression of type 2 diabetes

@en

P2093

M C Kjellsson

http://www.w3.org/2001/XMLSchema#string

M O Karlsson

http://www.w3.org/2001/XMLSchema#string

S Choy

http://www.w3.org/2001/XMLSchema#string

W de Winter

http://www.w3.org/2001/XMLSchema#string

P2860

Translating the A1C assay into estimated average glucose values

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Use and abuse of HOMA modeling

Correct homeostasis model assessment (HOMA) evaluation uses the computer program

Mechanisms linking obesity to insulin resistance and type 2 diabetes

The dynamics of human body weight change

Population PKPD modelling of the long-term hypoglycaemic effect of gliclazide given as a once-a-day modified release (MR) formulation.

Pathogenesis of type 2 diabetes mellitus.

Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c.

Red blood cells in sports: effects of exercise and training on oxygen supply by red blood cells

P304

11-19

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PSP4.12051

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26844011

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

4728293

http://www.w3.org/2001/XMLSchema#string

Weight-HbA1c-insulin-glucose model for describing disease progression of type 2 diabetes

about

P2860

P2860

Weight-HbA1c-insulin-glucose model for describing disease progression of type 2 diabetes

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932